Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SMMT
#683
Summit Therapeutics Inc. Common Stock
20.370
0
USD
+1.70%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.70%
Monthly Change
+26.68%
6 month change
+2.57%
Year Change
+2.57%
Previous Close
20.030
0
Open
20.240
0
Bid
Ask
Low
20.210
0
High
20.375
0
Volume
148
Markets
US Stock Market
Healthcare
SMMT
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
82.92 M
98.12 M
697.69 M
701.7 M
737.68 M
775.37 M
—
Valuation ratios
Enterprise value
323.29 M
192.16 M
3.14 B
1.89 B
13.07 B
13.34 B
58.1 B
Price to earnings ratio
-6.18
-2.8
-12.2
-2.67
-57.56
-12.15
-106.61
Price to sales ratio
379.96
137.16
1 371.18
—
—
-21.44 K
-242.26 K
Price to cash flow ratio
-6.79
-3.42
-23.25
-21.31
-90.23
-40.5
-253.14
Price to book ratio
4.11
2.98
7.63
21.06
32.98
19.85
53.73
Enterprise value to EBITDA ratio
-4.56
-1.82
-36.83
-2.91
-57.08
-12.1
-103.67
Profitability ratios
Return on assets %
-0.51
-0.78
-0.12
-3.03
-0.51
-1.44
-3.09
Return on equity %
-0.66
-1.06
-0.62
-7.91
-0.57
-1.64
-3.9
Return on invested capital %
-824.67
-1 235.4
-172.33
-1 492.71
-3 507.86
-10.84 K
—
Gross margin %
100
100
100
—
—
100
400
Operating margin %
-6 185.23
-4 764.29
-10.23 K
—
—
179.51 K
458.89 K
EBITDA margin %
-8 250.35
-5 848.92
-12.09 K
—
—
180.64 K
458.64 K
Net margin %
-6 127.56
-4 897.84
-11.17 K
—
—
176.98 K
456.03 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.41
3.8
16.93
9.3
10.15
9.87
29.42
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.02
0
0
0
-0
-0
Solvency ratios
Debt to assets ratio
—
—
—
0.52
0.02
—
—
Debt to equity ratio
—
—
—
1.37
0.02
—
—
Long term debt to total assets ratio
—
—
—
0.49
0
—
—
Long term debt to total equity ratio
—
—
—
1.29
0
—
—
Per share metrics
Operating cash flow per share
-0.69
-0.79
-0.22
-0.12
-0.2
-0.43
-0.43
EBIT per share
-1.04
-1.16
-0.45
-0.99
-0.31
-1.46
-1.47
EBITDA per share
-1.02
-1.15
-0.44
-0.99
-0.32
-1.47
-1.48
Total debt per share
—
—
—
0.17
0.01
—
—
Cash per share
0.96
0.78
1.8
0.3
0.57
0.95
2.17
Net current asset value per share
1.26
1.05
3.4
0.31
0.59
0.96
2.21
Tangible book value per share
0.95
0.77
0.65
0.12
0.54
0.88
1.94
Working capital per share
0.97
0.78
3.2
0.27
0.53
0.87
1.9
Book value per share
1.14
0.9
0.66
0.13
0.54
0.88
1.96
News
Why Is Ironwood (IRWD) Down 13.9% Since Last Earnings Report?
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
Jefferies downgrades Summit Therapeutics stock rating on trial risks
Micron and Facebook among market cap stock movers on Friday
Summit Therapeutics at The Citizens Life Sciences Conference: Strategic Insights on Ivonescimab
Summit Therapeutics Inc. (SMMT) Presents at The Citizens Life Sciences Conference 2026 Transcript
Summit Therapeutics at TD Cowen Conference: Strategic Focus on Ivonesimab
RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View
H.C. Wainwright cuts Summit Therapeutics stock price target on China trial timing uncertainty
SMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in Focus
Citizens reiterates Summit Therapeutics stock rating on pipeline expansion
Summit Therapeutics Inc. (SMMT) Q4 2025 Earnings Call Transcript